COMP <GO>
STOK vs ANIP // FREE CASH FLOW YIELD
Stoke Therapeutics Inc. (NASDAQ) VS. ANI Pharmaceuticals Inc. (NASDAQ) • 15-METRIC TALLY: STOK 4
— ANIP 6
▲ FREE CASH FLOW YIELD LEADER: ANIP
LAST: $26.35 (-0.23%) • MKT CAP: $1.70B
fcf-yield
2.64%
LAST: $73.16 (+2.02%) • MKT CAP: $1.68B
fcf-yield
10.20%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (STOK VS. ANIP)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | STOK | ANIP | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -6.10% | 16.00% | -22.10 | ANIP | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 13.7x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | 2.64% | 10.20% | -7.56 | ANIP | /fcf-yield <GO> |
| Operating Margin | -11.20% | 12.60% | -23.80 | ANIP | /operating-margins <GO> |
| Net Profit Margin | -3.70% | 8.80% | -12.50 | ANIP | /net-margins <GO> |
| Revenue Growth (YoY) | 180.00% | 43.80% | +136.20 | STOK | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.07% | -0.07 | ANIP | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 14.79 | 2.36 | +12.43 | STOK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 8/9 | -2.00 | ANIP | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 52.3 | 47.2 | +5.14 | STOK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 18.1x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.70B | $1.68B | $20.6M | STOK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | STOK REV | ANIP REV | STOK GROSS % | ANIP GROSS % | STOK FCF | ANIP FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $184.4M | $883.4M | — | — | $44.9M | $171.4M |
| FY 2024 | $36.6M | $614.4M | — | — | -$87.1M | $47.8M |
| FY 2023 | $8.8M | $486.8M | — | — | -$81.1M | $119.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
STOK // BETA —
ANIP // BETA —